Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.68 |
| ▸ | CES2 | O00748 | 1/20 | 0.68 |
| ▸ | CES1 | P23141 | 1/20 | 0.68 |
| ▸ | ELANE | P08246 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoin SCHEMBL21359843 | 0.85 | LMNA (0.75) | LMNACES2CES1ELANEALDH1A1 | |
| Benzoin SCHEMBL31362056 | 0.85 | LMNA (0.75) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL337105 | 0.84 | LMNA (0.88) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL8865268 | 0.84 | LMNA (0.88) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL3264348 | 0.84 | LMNA (0.68) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL15326953 | 0.83 | LMNA (0.72) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL23361760 | 0.83 | LMNA (0.78) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL183095 | 0.83 | LMNA (0.78) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL4910212 | 0.83 | LMNA (0.84) | LMNACES2CES1ALDH1A1KDM4E | |
| Benzoin SCHEMBL9490022 | 0.83 | LMNA (0.84) | LMNACES2CES1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4494825-A | Fill port seal with first and second photosensitizers | HITACHI, LTD. (JP) | 1985-01-22 | — | — | US | claimed |
| EP-2613632-A1 | CONTINUOUS PHOTOLYTIC PROCESS FOR THE PREPARATION OF VITAMIN D RELATED SUBSTANCES | Genzyme Corporation (US) | 2013-07-17 | — | — | EP | disclosed |
| US-20130172588-A1 | CONTINUOUS PHOTOLYTIC PROCESS FOR THE PREPARATION OF VITAMIN D RELATED SUBSTANCES | GENZYME CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| WO-2012033703-A1 | CONTINUOUS PHOTOLYTIC PROCESS FOR THE PREPARATION OF VITAMIN D RELATED SUBSTANCES | GENZYME CORPORATION (US) | 2012-03-15 | — | — | WO | disclosed |
| US-4494825-A | Fill port seal with first and second photosensitizers | HITACHI, LTD. (JP) | 1985-01-22 | — | — | US | disclosed |
| US-4191320-A | THERMOPLASTIC RESIN, TWO AROMATIC CARBONYL SENSITIZERS | OWENS-ILLINOIS, INC. (US) | 1980-03-04 | — | — | US | disclosed |
| US-4056665-A | Composition and process | OWENS-ILLINOIS, INC. (US) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172588-A1 | CONTINUOUS PHOTOLYTIC PROCESS FOR THE PREPARATION OF VITAMIN D RELATED SUBSTANCES | VDR, CYP24A1, CYP2R1 | LMNA 1022/4885CES2 1932/4885CES1 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.